← Back to Search

Behavioral Intervention

Health Communication Tool + SDoH Screening for Lung Cancer

N/A
Recruiting
Led By Lisa Carter-Bawa, PhD
Research Sponsored by Hackensack Meridian Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Aged 50 years to 80 years
20 pack-year smoking history
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months post intervention
Awards & highlights

Study Summary

This trial aims to increase lung cancer screening rates, understanding of effective screening strategies, and reduce lung cancer burden through a tailored health communication & decision support tool combined with social determinants of health (SDoH) screening.

Who is the study for?
This trial is for individuals aged 50-80 who can consent, currently smoke or quit within the last 15 years, have a history of significant smoking (20 pack-years), and have never had lung cancer screening. They must speak and understand English. Those with previous lung screenings or diagnosed with lung cancer are excluded.Check my eligibility
What is being tested?
The study tests if adding a Social Determinants of Health (SDoH) assessment and referral process to a community-based educational tool improves lung cancer screening rates compared to just the educational tool alone in at-risk communities.See study design
What are the potential side effects?
Since this trial focuses on education and social assessments rather than medical treatments, there are no direct side effects like those seen with drugs or surgeries. However, participants may experience stress or anxiety related to learning about their health risks.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 50 and 80 years old.
Select...
I have smoked the equivalent of a pack a day for 20 years.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months post intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months post intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Lung cancer screening uptake
Secondary outcome measures
Health Literacy
Knowledge of Lung Cancer and Lung Screening
Lung Cancer Fatalism
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Social determinants of health screeningExperimental Treatment2 Interventions
Participants will receive a social determinants of health screening assessment and referral process in addition to the community-based lung cancer screening educational tool.
Group II: Community-based lung cancer screeningActive Control1 Intervention
Participants will receive a community-based lung cancer screening educational tool.

Find a Location

Who is running the clinical trial?

Hackensack Meridian HealthLead Sponsor
131 Previous Clinical Trials
28,144 Total Patients Enrolled
Becton, Dickinson and CompanyIndustry Sponsor
70 Previous Clinical Trials
88,486 Total Patients Enrolled
Lisa Carter-Bawa, PhDPrincipal InvestigatorHackensack Meridian Health
2 Previous Clinical Trials
520 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the eligibility requirements to participate in this clinical trial?

"This study is looking to recruit roughly 100 patients with lung cancer between the ages of 50 and 80."

Answered by AI

Is the recruitment of seniors being welcomed for this test?

"Applicants aged 50 to 80 are eligible for this medical trial, however there are more studies available for both younger and older patients; 43 trials exist below the age of 18 while 1642 can be found above 65 years old."

Answered by AI

Are participants currently being recruited for this experiment?

"Unfortunately, this clinical trial is not presently recruiting. Initially posted on September 30th 2023 and last updated 19 days later on the 19th of September, 1649 other medical studies are actively seeking patients at this time."

Answered by AI
Recent research and studies
~42 spots leftby Sep 2024